Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04405258

Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial

Randomized Clinical Trial of Additional Left Atrial Posterior Wall Isolation for Persistent Atrial Fibrillation

Status
Active Not Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
276 (actual)
Sponsor
Institute for Clinical Effectiveness, Japan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose for this study is to determine whether left posterior wall isolation (PWI) in addition to pulmonary vein isolation (PVI) is effective as ablation strategy for persistent atrial fibrillation (AF).

Detailed description

PVI is cornerstone of AF ablation. However, clinical outcome of only PVI in patients with persistent AF is insufficient due to AF substrate extending to left atrium. Strategy of catheter ablation for persistent AF is not established despite attempts of numerous left atrial substrate modifications. Additional PWI on PVI is one of expected effective strategies for persistent AF, because PW originated from common tissue of PV and is considered to play a part in AF trigger and maintenance. However, this strategy is also not established in the recent international consensus statement. Following two reasons are considered. One is the procedural difficulty in creating durable PWI, and another is the existence of patients who can recover by only PVI. The latest technology, ablation index, can create durable PVI, and may create durable PWI. Several reports suggested that PVI only strategy was sufficient in the patients with persistent AF who could maintain sinus rhythm after pharmacological or electrical cardioversion. Therefore, we planed this randomized clinical trial that compared between PVI alone and additional PWI on PVI using ablation index in the patients with persistent AF without pharmacological sinus rhythm conversion.

Conditions

Interventions

TypeNameDescription
PROCEDUREPulmonary vein isolationPulmonary vein isolation, superior vena cava isolation, and cavotricuspid isthmus ablation
PROCEDURELeft posterior wall isolationPulmonary vein isolation, superior vena cava isolation, cavotricuspid isthmus ablation, and left posterior wall isolation

Timeline

Start date
2020-06-08
Primary completion
2025-12-31
Completion
2026-06-30
First posted
2020-05-28
Last updated
2024-06-14

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT04405258. Inclusion in this directory is not an endorsement.